Source: GlobeNewswire Inc.
Law firm Bronstein Gewirtz & Grossman has filed class action lawsuits against three companies for alleged securities fraud. Chemours is accused of overstating Opteon product demand and providing unreliable financial guidance during February-August 2026. Everest Group and Fluence Energy face similar securities violation allegations. Investors have until specified deadlines to join the lawsuits.
Source: GlobeNewswire Inc.
Law firm Bronstein Gewirtz & Grossman has filed class action lawsuits against three companies for alleged securities fraud violations. Everest Group is accused of making false statements about casualty risk exposure, inadequate pricing, and insufficient reserves during the February 2024 to October 2025 period. Similar class actions have been filed against Fluence Energy and Chemours Company. Investors who purchased securities during the class periods are encouraged to seek recovery.
Source: GlobeNewswire Inc.
Law firm Bronstein Gewirtz & Grossman has filed class action lawsuits against three companies for alleged securities fraud. Fluence Energy is accused of making false statements about its ability to deliver backlog and meet fiscal 2026 guidance due to incomplete manufacturing facilities and unresolved production problems. Everest Group and Chemours also face similar securities fraud allegations. Investors who purchased securities during specified class periods are encouraged to seek recovery.
Source: GlobeNewswire Inc.
Chemours faces a securities class action lawsuit for failing to disclose material information about refrigerant aftermarket demand during February-August 2026. The company cut its full-year adjusted EBITDA guidance and admitted to channel oversupply, resulting in an 18.63% stock price decline on August 5, 2026. Investors have until December 7, 2026 to file lead plaintiff applications.
Source: GlobeNewswire Inc.
Pomerantz LLP has filed a class action lawsuit against The Chemours Company (NYSE: CC) for alleged securities fraud. The complaint alleges that Chemours made false statements about demand for its Opteon refrigeration products and overstated aftermarket demand. On August 4, 2026, Chemours reduced its full-year EBITDA guidance and disclosed a $65 million oversupply issue, causing the stock to fall 18.63%. Investors who purchased Chemours securities between February 20 and August 4, 2026 can join the class action by December 7, 2026.
Source: GlobeNewswire Inc.
Law firm Bronstein, Gewirtz & Grossman, LLC has announced class action lawsuits against three companies for alleged securities fraud violations. Fluence Energy is accused of making false statements about its ability to deliver backlog and meet fiscal 2026 guidance due to incomplete manufacturing facilities and unresolved production problems. Similar class actions have been filed against Everest Group and Chemours Company, with lead plaintiff deadlines in late 2026.
Source: GlobeNewswire Inc.
Three class action lawsuits have been filed against Chemours Company, Everest Group, Ltd., and Fluence Energy, Inc. for alleged securities fraud violations. Chemours is accused of overstating aftermarket demand for Opteon products and providing unreliable financial guidance. Investors in all three companies are encouraged to seek recovery, with lead plaintiff deadlines ranging from November 30, 2026 to December 28, 2026.
Source: GlobeNewswire Inc.
Law firm Bronstein, Gewirtz & Grossman, LLC has announced class action lawsuits against three companies for alleged securities fraud violations. Everest Group is accused of making false statements about casualty risk exposure, inadequate pricing, and insufficient reserves. Chemours and Fluence Energy also face similar securities fraud allegations. Investors who purchased securities during specified periods are eligible to seek recovery.
Source: GlobeNewswire Inc.
Law firm Bronstein Gewirtz & Grossman has filed class action lawsuits against three companies for alleged securities fraud violations. Everest Group is accused of making false statements about casualty risk exposure and inadequate reserve pricing. Arbor Realty Trust and Chemours Company face similar allegations. Investors who purchased securities during specified periods are eligible to seek recovery.
Source: GlobeNewswire Inc.
A class action lawsuit has been filed against Chemours Company (NYSE: CC) for alleged securities fraud. The complaint alleges that Chemours materially overstated aftermarket demand for Opteon products, failed to disclose decreasing demand, and provided unreliable financial guidance for 2026. Investors who purchased CC securities between February 20, 2026 and August 4, 2026 may be eligible to recover losses, with a lead plaintiff deadline of December 7, 2026.
Source: GlobeNewswire Inc.
Chemours faces a securities class action lawsuit for allegedly failing to disclose material information about refrigerant aftermarket demand during February-August 2026. The company cut full-year EBITDA guidance and admitted to channel oversupply, resulting in an 18.63% stock price decline on August 5, 2026. Investors have until December 7, 2026 to file lead plaintiff applications.
Source: GlobeNewswire Inc.
Bronstein, Gewirtz & Grossman, LLC has filed class action lawsuits against Lululemon Athletica, Chemours Company, and O-I Glass for alleged securities fraud. Lululemon is accused of failing to disclose deteriorating store traffic and demand due to negative media commentary and weak product launches, while misrepresenting its financial guidance and turnaround plans. Investors in these companies during specified periods are encouraged to seek recovery.
Source: GlobeNewswire Inc.
A class action lawsuit has been filed against Chemours Company alleging that executives failed to disclose material information about overstated aftermarket demand for Opteon products and decreasing demand, resulting in unreliable financial guidance. Investors who purchased Chemours securities between February 20, 2026 and August 4, 2026 are encouraged to join the case, with a lead plaintiff deadline of December 7, 2026.
Source: GlobeNewswire Inc.
A class action lawsuit has been filed against Chemours Company alleging that the company failed to disclose material information about overstated aftermarket demand for Opteon products and decreasing demand, resulting in unreliable financial guidance. Investors who purchased Chemours securities between February 20, 2026 and August 4, 2026 are encouraged to join the case, with a lead plaintiff deadline of December 7, 2026.
Source: Zacks Investment Research
Chemours has launched Faizeon two-phase liquid cooling solutions designed for AI and high-density data centers. The portfolio includes five specialized dielectric fluids for direct-to-chip and immersion cooling, with independent testing showing Faizeon 200 maintaining GPU temperatures up to 19°C lower than water-based systems while reducing energy consumption and water usage. The company is collaborating with multiple partners to accelerate adoption.